Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Not yet recruiting 1No longer available 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Expanded_access 1

Sponsor

Cancer Type

CNS 3

Conditions

Glioblastoma 3Urinary Bladder Neoplasms 1Rhabdoid Tumor 1Recurrence 1Prostatic Neoplasms 1Multiple Myeloma 1Lymphoma 1Glioma 1Diffuse Intrinsic Pontine Glioma 1Brain Neoplasms 1

Interventions

Temozolomide 405Radiotherapy 202Bevacizumab 157Radiation 80Magnetic Resonance Spectroscopy 77Lomustine 49Surgical Procedures, Operative 45Carmustine 41pembrolizumab 40Irinotecan 38Nivolumab 32Specimen Handling 28Carboplatin 27Radiosurgery 24Erlotinib Hydrochloride 24Drug Therapy 23Chemotherapy, Adjuvant 23Radiotherapy, Intensity-Modulated 22Cyclophosphamide 20Aminolevulinic Acid 20O(6)-benzylguanine 17sargramostim 16Radiotherapy, Conformal 15Blood Specimen Collection 15temsirolimus 14Granulocyte-Macrophage Colony-Stimulating Factor 14Everolimus 14Vorinostat 13Sorafenib 13Ipilimumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Glioblastoma × gallium maltolate × Clear all
NCT07515924 2026-04-07

Oral Gallium Maltolate for Recurrent Glioblastoma

Medical College of Wisconsin

Phase EARLY_PHASE1 Not yet recruiting
8 enrolled
CNS

Glioblastoma

NCT06404034 2026-03-04

Expanded Access to Gallium Maltolate (GaM)

Imaging Biometrics, LLC

No longer available
CNS

Glioblastoma

NCT04319276 2025-11-03

Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma

Medical College of Wisconsin

Phase 1 Active not recruiting
26 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡